A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases characterized by pulmonary inflammation, is pleased to announce ...

Once a person starts treatment for schizophrenia, family and friends should be on the lookout for signs of relapse — new hallucinations, delusions, social withdrawal, disorganized thinking ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.